February 13, 2024

Newly found Huntington’s disease mechanism is ‘one piece of puzzle’ – Huntington’s Disease News

February 8, 2024

Immunotherapies in Huntington’s disease and α-Synucleinopathies – Frontiers

February 5, 2024

Targeting Tau to Treat Clinical Features of Huntington’s Disease – Frontiers

January 24, 2024

Safety and efficacy of laquinimod for Huntington’s disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study – The Lancet

January 5, 2024

A new year and fresh hope for Huntington’s disease treatments – Huntington’s Disease News